-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Applied Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
- Applied Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$68.6M, a 61.9% decline year-over-year.
- Applied Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$187M, a 94.1% decline year-over-year.
- Applied Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$120M, a 45.2% decline from 2022.
- Applied Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$82.5M, a 21.9% increase from 2021.
- Applied Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$106M, a 12.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)